Antibiotic therapy in febrile neutropenia in haematological patients: current considerations and future challenges
Revista Española de Quimioterapia · 29.09.2026 · 39 (5) · 387
DOI: 10.37201/req/165.2026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Revista Española de Quimioterapia, online erschienen am 20.05.2026. Verfasst von Carolina García-Vidal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Ba…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Febrile Neutropenia, Hematologic Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The management of febrile neutropenia (FN) in oncohematological patients is undergoing a paradigm shift driven by a deeper understanding of patients’ pathophysiological heterogeneity, the increasing speed and accuracy of microbiological diagnostics, the emergence of new antibiotics, and the incorporation of predictive artificial intelligence (AI) as a tool to support clinical decision-making. Our objective is to provide an updated and comprehensive overview of the factors influencing antibiotic treatment in FN. We propose that its management should be based on three essential pillars. First, accurate risk stratification for bacterial infection. Second, ensuring that patients receive appropriate empirical antibiotic therapy, tailoring the initial choice according to the results of surveillance cultures from oropharyngeal and/or fecal microbiota. Finally, prioritizing antibiotic choices that preserve intestinal microbiota eubiosis as much as possible. Reducing colonization and overgrowth of facultative aerobic/anaerobic flora (Enterobacteriaceae, non-fermenting Gram-negative bacilli, and Enterococcus spp.) while preserving strict anaerobic flora decreases the risk of bacterial translocation and complications such as graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) or loss of CAR-T functionality. This decision model, grounded in objective criteria, aims to balance the need for effective empirical coverage with responsible antibiotic use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
- Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. cgarciav@clinic.cat.
- Department of Infectious Diseases, Germans Trias i Pujol University Hospital, Badalona, Spain.
- Fundació Lluita contra les Infeccions, Badalona, Spain.
- Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
ORCID-Profile: Carolina García-Vidal, Antonio Gallardo-Pizarro, Tommaso Francesco Aiello, Mi Kwon, Miguel Salavert, Cristina Pitart, María Suarez-Lledó, Alex Soriano, Josep Mensa
Zitieren
APA
García-Vidal, C., Gallardo-Pizarro, A., Aiello, T. F., Kwon, M., Salavert, M., Pitart, C., Suarez-Lledó, M., Soriano, A., & Mensa, J. (2026). Antibiotic therapy in febrile neutropenia in haematological patients: current considerations and future challenges. Revista Española de Quimioterapia, 39(5), 387. https://doi.org/10.37201/req/165.2026
Vancouver
García-Vidal C, Gallardo-Pizarro A, Aiello TF, Kwon M, Salavert M, Pitart C, et al. Antibiotic therapy in febrile neutropenia in haematological patients: current considerations and future challenges. Revista Española de Quimioterapia. 2026;39(5):387. doi:10.37201/req/165.2026
BibTeX
@article{GarcaVidal2026,
author = {García-Vidal, Carolina and Gallardo-Pizarro, Antonio and Aiello, Tommaso Francesco and Kwon, Mi and Salavert, Miguel and Pitart, Cristina and Suarez-Lledó, María and Soriano, Alex and Mensa, Josep},
title = {Antibiotic therapy in febrile neutropenia in haematological patients: current considerations and future challenges},
journal = {Revista Española de Quimioterapia},
year = {2026},
volume = {39},
number = {5},
pages = {387},
doi = {10.37201/req/165.2026}
}
EUVIMED